More specifically, the present invention relates to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus , compositions comprising {TAIL ~ such compounds}, methods for inhibiting HCV viral replication, methods for treating or preventing HCV infection, and {HEAD ~ processes} for making the compounds 
More specifically , the present invention relates to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus , compositions comprising { TAIL ~ such compounds } , methods for inhibiting HCV viral replication , methods for treating or preventing HCV infection , and { HEAD ~ processes } for making the compounds
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH